Login / Signup

Whole-genome long-read sequencing downsampling and its effect on variant-calling precision and recall.

William T HarveyPeter EbertJana EblerPeter A AudanoKatherine M MunsonKendra HoekzemaDavid PorubskyChristine R BeckTobias MarschallKiran V GarimellaEvan E Eichler
Published in: Genome research (2023)
Advances in long-read sequencing (LRS) technologies continue to make whole-genome sequencing more complete, affordable, and accurate. LRS provides significant advantages over short-read sequencing approaches, including phased de novo genome assembly, access to previously excluded genomic regions, and discovery of more complex structural variants (SVs) associated with disease. Limitations remain with respect to cost, scalability, and platform-dependent read accuracy and the tradeoffs between sequence coverage and sensitivity of variant discovery are important experimental considerations for the application of LRS. We compare the genetic variant-calling precision and recall of Oxford Nanopore Technologies (ONT) and Pacific Biosciences (PacBio) HiFi platforms over a range of sequence coverages. For read-based applications, LRS sensitivity begins to plateau around 12-fold coverage with a majority of variants called with reasonable accuracy (F 1 score above 0.5), and both platforms perform well for SV detection. Genome assembly increases variant-calling precision and recall of SVs and indels in HiFi data sets with HiFi outperforming ONT in quality as measured by the F 1 score of assembly-based variant call sets. While both technologies continue to evolve, our work offers guidance to design cost-effective experimental strategies that do not compromise on discovering novel biology.
Keyphrases
  • single molecule
  • copy number
  • single cell
  • small molecule
  • high throughput
  • genome wide
  • healthcare
  • dna methylation
  • artificial intelligence
  • amino acid
  • affordable care act
  • sensitive detection
  • quantum dots